Gladstone NOW: The Campaign Join Us on the Journey ✕
16 - 30 of 1316 Results Clear All
Gladstone scientists developed a computational approach that accurately distinguishes cells of different identities or characteristics in complex biological samples used in diverse areas of biomedical and discovery research.
News Release Research (Publication) Corces Lab
Gladstone scientists Katie Pollard and Ketrin Gjoni answer questions about their latest study, which appears in the journal Nature Methods.
News Release Research (Publication) Data Science and Biotechnology Pollard Lab Genomics Human Genetics
Gladstone's president gave the mayor a tour of the facilities and showed him beating heart cells under the microscope.
Gladstone scientists created a new tool to understand the immune system’s inner workings when confronted with a virus.
Research (Publication) HIV/AIDS Virology Roan Lab
Melanie Ott talks about the ongoing measles outbreak, explains how vaccination can lower the risk of Alzheimer’s, and shares other positive “side effects” of vaccines.
Gladstone Experts Virology
KUSI News—Melanie Ott, director of the Gladstone Institute of Virology, explains that measles can have severe and lasting consequences in some people, especially children, and that the measles vaccine provides life-long protection in the vast majority of vaccinated people.
Gladstone Experts Virology Ott Lab
Isha Jain and Skyler Blume explain the science behind their discovery and the impact it could have for mitochondrial diseases.
Research (Publication) Jain Lab
The Washington Post—As it explores whether reprogramming our genes can make us young again, this article highlights the Noble Prize winning discovery by Gladstone Investigator Shinya Yamanaka. (Subscription required.)
Gladstone Experts Yamanaka Lab Stem Cells/iPSCs
amfAR News—In an interview with the Foundation for AIDS Research, Melanie Ott, director of the Gladstone Institute of Virology, discusses the future of HIV research, and describes how lessons from the field have laid a strong foundation for fighting other viral diseases.
Gladstone Experts HIV/AIDS Virology Ott Lab
The San Francisco Experience—In a podcast interview, Gladstone President Deepak Srivastava discusses the mission of Gladstone Institutes, and describes how advances in stem cell biology, genome engineering, and artificial intelligence are making it possible to understand the core of diseases and develop new cures.
Gladstone Experts Srivastava Lab AI CRISPR/Gene Editing Stem Cells/iPSCs
Bruneau, director of the Gladstone Institute of Cardiovascular Disease, shares exciting recent advances in heart research and talks about the impact of predictive AI.
Gladstone Experts Heart Failure Cardiovascular Disease Alexanian Lab Bruneau Lab Pollard Lab Theodoris Lab AI
Award of Excellence recipient Ada Zhu discusses her work in the Alexanian lab, how a personal connection to heart disease drives her work, and advice she has for budding scientists.
Research Associates Committee Profile
Science Alert—Gladstone Investigator Isha Jain and her colleagues developed a drug that reduces oxygen delivery from blood to tissues and could help prevent brain damage caused by diseases that cause a toxic oxygen buildup.
Jain Lab Cardiovascular Disease
Nature—Gladstone Assistant Investigator Christina Theodoris salutes the biggest-ever AI biology model as a significant step towards understanding how DNA regulates gene expression.
Theodoris Lab Data Science and Biotechnology Gladstone Experts
Gladstone researchers develop a drug that mimics the cellular effects of low-oxygen therapy for the treatment of inherited mitochondrial diseases.
News Release Research (Publication) Jain Lab
